<p>前威斯康星州州长和美国卫生与公共服务部部长为透皮药物输送技术的先锋带来了丰富的医疗领导经验</p>
<p>, /PRNewswire/ -- Vector Science &amp; Therapeutics 今日宣布，前威斯康星州州长和美国卫生与公共服务部部长汤米·汤普森已加入公司，担任董事会主席。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>汤米·汤普森</p>
<p>汤普森的任命为 Vector 带来了卓越的医疗政策专业知识和领导经验，帮助公司推进其使命，即为医生、外科医生和临床医生提供精准干预措施，以应对精确性至关重要且系统性风险不可接受的情况。公司的开发工作集中在疼痛管理、再生医学、骨科和癌症领域。汤普森的杰出职业生涯包括担任威斯康星州最长任期的州长（1987-2001）以及在乔治·W·布什总统任内领导美国卫生与公共服务部（2001-2005），期间他监督了医疗保险现代化和重大医疗保健倡议。</p>
<p>在担任卫生与公共服务部部长期间，汤普森倡导医疗创新，监督实施医疗保险处方药福利，并领导国家医疗基础设施的现代化工作。作为威斯康星州州长，他因开创福利改革和促进经济发展而闻名，特别是在医疗保健和生物技术领域。</p>
<p>汤普森表示：“Vector Science &amp; Therapeutics 正是我们应对现代医疗挑战所需的创新思维。Vector 的透皮药物输送平台将在靶向治疗输送方面带来重大进展，有潜力提高治疗效果，同时最小化系统性副作用。随着我们的人口老龄化并越来越依赖多种药物治疗各种疾病，将生物机械和治疗干预措施输送到目标解剖部位变得越来越重要。我很高兴能与整个 Vector 团队合作，推动这些突破性技术的发展。”</p>
<p>在他的职业生涯中，汤普森一直是医疗创新的坚定倡导者，并在众多医疗相关的董事会和咨询委员会中任职。他在复杂的监管环境中导航的经验以及对公共和私营部门医疗动态的理解，将对 Vector 继续开发和商业化其治疗平台至关重要。</p>
<p>Vector Science &amp; Therapeutics 首席执行官比尔·杰克逊表示：“我们很荣幸欢迎汤米·汤普森担任我们的董事会主席。他在医疗政策方面的无与伦比的经验，加上他对威斯康星州创新生态系统的深刻理解，使他成为引导 Vector 战略方向的理想领导者，因为我们致力于将突破性的生物机械和透皮输送疗法带给临床医生和患者。”</p>
<p><strong>关于 Vector Science &amp; Therapeutics</strong></p>
<p>Vector Science &amp; Therapeutics 成立于 2024 年，位于威斯康星州梅奎恩，开发主动透皮和局部药物输送平台，以为临床医生提供精准干预措施，以应对精确性至关重要且系统性风险不可接受的情况。Vector Science &amp; Therapeutics 在多伦多证券交易所创业板上市，股票代码为 PAIN。有关更多信息，请访问 https://vectorscience.co/.</p>
<p>来源：Vector Sciences &amp; Therapeutics</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy"/></p>

VTVT

RTSL

生物科技 ETF - VanEck Vectors

动态生物技术与基因组 ETF - Invesco

标普生物技术 ETF - SPDR

纳斯达克生物科技指数 ETF - iShares Nasdaq

2 倍做多纳斯达克生物技术 ETF - ProShares

医药突破 ETF - ALPS

标普生物技术 3 倍做多 - Direxion

纽交所高增长板生物技术指数 ETF - First Trust

<p>Vector Science & Therapeutics 任命前威斯康星州州长和美国卫生与公共服务部部长汤米·汤普森（Tommy Thompson）为董事会主席。汤普森为公司带来了丰富的医疗保健领导和政策专业知识，该公司专注于经皮药物输送技术。他的经验包括监督重大医疗保健倡议和倡导医疗保健创新。首席执行官比尔·杰克逊（Bill Jackson）对汤普森能够引导公司战略方向以开发突破性疗法表示信心</p>

<p>Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology</p>
<div class="lb-trans"><p>前威斯康星州州长和美国卫生与公共服务部部长为透皮药物输送技术的先锋带来了丰富的医疗领导经验</p>
</div><p>, /PRNewswire/ -- Vector Science &amp; Therapeutics today announced that Tommy Thompson, former Governor of Wisconsin and U.S. Secretary of Health and Human Services, has joined the company as Chairman of the Board.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Vector Science &amp; Therapeutics 今日宣布，前威斯康星州州长和美国卫生与公共服务部部长汤米·汤普森已加入公司，担任董事会主席。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Tommy Thompson</p>
<div class="lb-trans"><p>汤米·汤普森</p>
</div><p>Thompson's appointment brings exceptional healthcare policy expertise and leadership experience to Vector as the company advances its mission to equip physicians, surgeons, and clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. The company's developmental work is focused in pain management, regenerative medicine, orthopedics, and cancer. Thompson's distinguished career includes serving as Wisconsin's longest-serving governor (1987-2001) and leading the U.S. Department of Health and Human Services under President George W. Bush (2001-2005), where he oversaw Medicare modernization and major healthcare initiatives.</p>
<div class="lb-trans"><p>汤普森的任命为 Vector 带来了卓越的医疗政策专业知识和领导经验，帮助公司推进其使命，即为医生、外科医生和临床医生提供精准干预措施，以应对精确性至关重要且系统性风险不可接受的情况。公司的开发工作集中在疼痛管理、再生医学、骨科和癌症领域。汤普森的杰出职业生涯包括担任威斯康星州最长任期的州长（1987-2001）以及在乔治·W·布什总统任内领导美国卫生与公共服务部（2001-2005），期间他监督了医疗保险现代化和重大医疗保健倡议。</p>
</div><p>During his tenure as HHS Secretary, Thompson championed healthcare innovation, oversaw the implementation of the Medicare Prescription Drug Benefit, and led efforts to modernize the nation's healthcare infrastructure. As Wisconsin Governor, he was known for pioneering welfare reform and promoting economic development, particularly in the healthcare and biotechnology sectors.</p>
<div class="lb-trans"><p>在担任卫生与公共服务部部长期间，汤普森倡导医疗创新，监督实施医疗保险处方药福利，并领导国家医疗基础设施的现代化工作。作为威斯康星州州长，他因开创福利改革和促进经济发展而闻名，特别是在医疗保健和生物技术领域。</p>
</div><p>&#34;Vector Science &amp; Therapeutics represents exactly the kind of innovative thinking we need to address the challenges facing modern healthcare,&#34; said Thompson. &#34;Vector's transdermal drug delivery platforms will deliver significant advances in targeted therapy delivery, offering the potential to improve treatment efficacy while minimizing systemic side effects. Delivering biomechanical and therapeutic interventions into targeted anatomy is becoming increasingly important as our population ages and becomes increasingly dependent on poly pharmacy for a range of conditions. I am excited to work with the entire Vector team to help advance these breakthrough technologies.&#34;</p>
<div class="lb-trans"><p>汤普森表示：“Vector Science &amp; Therapeutics 正是我们应对现代医疗挑战所需的创新思维。Vector 的透皮药物输送平台将在靶向治疗输送方面带来重大进展，有潜力提高治疗效果，同时最小化系统性副作用。随着我们的人口老龄化并越来越依赖多种药物治疗各种疾病，将生物机械和治疗干预措施输送到目标解剖部位变得越来越重要。我很高兴能与整个 Vector 团队合作，推动这些突破性技术的发展。”</p>
</div><p>Throughout his career, Thompson has been a strong advocate for healthcare innovation and has served on numerous healthcare-related boards and advisory committees. His experience navigating complex regulatory environments and understanding of both public and private sector healthcare dynamics will be invaluable as Vector continues to develop and commercialize its therapeutic platforms.</p>
<div class="lb-trans"><p>在他的职业生涯中，汤普森一直是医疗创新的坚定倡导者，并在众多医疗相关的董事会和咨询委员会中任职。他在复杂的监管环境中导航的经验以及对公共和私营部门医疗动态的理解，将对 Vector 继续开发和商业化其治疗平台至关重要。</p>
</div><p>&#34;We are honored to welcome Tommy Thompson as Chairman of our Board,&#34; said Bill Jackson, Chief Executive Officer of Vector Science &amp; Therapeutics. &#34;His unparalleled experience in healthcare policy, combined with his deep understanding of Wisconsin's innovation ecosystem, makes him the ideal leader to guide Vector's strategic direction as we work to bring breakthrough biomechanical and transdermally delivered therapies to clinicians and patients.&#34;</p>
<div class="lb-trans"><p>Vector Science &amp; Therapeutics 首席执行官比尔·杰克逊表示：“我们很荣幸欢迎汤米·汤普森担任我们的董事会主席。他在医疗政策方面的无与伦比的经验，加上他对威斯康星州创新生态系统的深刻理解，使他成为引导 Vector 战略方向的理想领导者，因为我们致力于将突破性的生物机械和透皮输送疗法带给临床医生和患者。”</p>
</div><p><strong>About Vector Science &amp; Therapeutics</strong></p>
<div class="lb-trans"><p><strong>关于 Vector Science &amp; Therapeutics</strong></p>
</div><p>Founded in 2024 and located in Mequon, Wisconsin, Vector Science &amp; Therapeutics develops active transdermal and localized drug delivery platforms to equip clinicians with site-directed interventions where precision matters and systemic risk is unacceptable. Vector Science &amp; Therapeutics is publicly traded on the TSX Venture Exchange under the ticker symbol PAIN. For more information, visit https://vectorscience.co/.</p>
<div class="lb-trans"><p>Vector Science &amp; Therapeutics 成立于 2024 年，位于威斯康星州梅奎恩，开发主动透皮和局部药物输送平台，以为临床医生提供精准干预措施，以应对精确性至关重要且系统性风险不可接受的情况。Vector Science &amp; Therapeutics 在多伦多证券交易所创业板上市，股票代码为 PAIN。有关更多信息，请访问 https://vectorscience.co/.</p>
</div><p>SOURCE Vector Sciences &amp; Therapeutics</p>
<div class="lb-trans"><p>来源：Vector Sciences &amp; Therapeutics</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDMwJk5ld3NJdGVtSWQ9TEE0NzU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MzAwODEyUFJfTkVXU19VU1BSX19fX19MQTQ3NTQy" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA47542&amp;Transmission_Id=202604300812PR_NEWS_USPR_____LA47542&amp;DateId=20260430"/></p>

08:12 ETVector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board

prnewswire

vTv Therap

Rapid Therapeutic Science Laboratories, Inc.

Vector Science & Therapeutics 宣布 Tommy Thompson 担任董事会主席